CAPR
Capricor Therapeutics, Inc.
There isn't enough reported data to score CAPR yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
CAPR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
CAPR's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
CAPR PE Valuation
CAPR has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
CAPR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CAPR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CAPR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.64 | -$0.89 |
| Q2 2026 | -$2.45 | -$0.86 |
| Q1 2026 | -$2.32 | -$0.95 |
| Q4 2025 | -$2.26 | -$1.11 |
| Q3 2025 | -$1.75 | -$0.68 |
| Q2 2025 | -$1.59 | -$0.65 |
| Q1 2025 | -$1.37 | -$0.49 |
| Q4 2024 | -$1.15 | -$0.27 |
CAPR lost $2.64 per share over the past year, a bigger loss than the year before.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over CAPR on earnings, with more consistent year-over-year improvement.
CAPR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $11.1M | -7.9% |
| Q3 2024 | $2.3M | -63% |
| Q2 2024 | $4M | +1.4% |
| Q1 2024 | $4.9M | +64% |
| Q4 2023 | $12.1M | +1159% |
| Q3 2023 | $6.2M | +289% |
| Q2 2021 | $204.1K | +309% |
| Q1 2021 | $40.8K | -78% |
HIMS has the stronger quarterly revenue trend. Revenue is down 7.9% for CAPR versus up 49% for HIMS.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -69% | -59 points |
| Q3 2024 | -575% | -464 points |
| Q2 2024 | -292% | -94 points |
| Q1 2024 | -209% | +65 points |
| Q4 2023 | -11% | +830 points |
| Q3 2023 | -111% | +296 points |
| Q2 2023 | -198% | N/A |
| Q1 2023 | -274% | N/A |
CAPR's operating margin was −69% last quarter, down 59 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
CAPR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$37.5M | -$17.8M |
| Q2 2026 | -$35.5M | -$15.1M |
| Q1 2026 | -$34.4M | -$27M |
| Q4 2025 | -$25.2M | -$9.9M |
| Q3 2025 | -$19.7M | -$8.1M |
| Q2 2025 | -$20.4M | -$8.1M |
| Q1 2025 | -$7.3M | -$5.5M |
| Q4 2024 | -$15.3M | -$3.1M |
CAPR has burned cash in almost every quarter: −$133M over the past year, against −$63M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over CAPR on cash generation, producing positive trailing cash flow while its opponent burns cash.
CAPR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +202K shares |
| 1 year | +27% | +12.4M shares |
| 3 years | +129% | +32.8M shares |
| 5 years | +154% | +35.3M shares |
| Available history | +745% | +51.2M shares |
CAPR has 58M diluted shares, up 27% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over CAPR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
CAPR Net Leverage
CAPR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
CAPR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 67.4 | Neutral |
CAPR's weekly RSI is 44 (neutral) and its Stochastic is 67 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
CAPR PE vs Healthcare Sector
CAPR has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
CAPR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.92 | 29% above |
| 20 week MA | $10.2 | 0.1% above |
| 50 week MA | $20.9 | 51% below |
| 100 week MA | $15.5 | 34% below |
| 200 week MA | $10.8 | 5.4% below |
CAPR has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CAPR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.16 | $3.90 | +236% |
| 2021 | $3.90 | $3.39 | -13% |
| 2022 | $3.39 | $3.52 | +3.8% |
| 2023 | $3.52 | $4.89 | +39% |
| 2024 | $4.89 | $14.1 | +188% |
| 2025 | $14.1 | $29.7 | +111% |
| 2026 YTD | $29.7 | $10.2 | -66% |
CAPR is down 66% so far in 2026, after finishing higher in five of the previous six years.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over CAPR on returns for 2026, with the stronger performance.